SLN and MKKGY Related Headlines

Go Back

Oct 19, 2026 08:00AM Merck KGaA to acquire Silence Therapeutics for $1.1B

Oct 19, 2026 08:00AM Merck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset

SLN and MKKGY Related Press Releases

Go Back

Oct 19, 2026 08:00AM Merck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset

SLN and MKKGY Related SEC Filings

Go Back